List of Excipients in API NAFTIFINE HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing NAFTIFINE HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merz Pharmaceuticals LLC | NAFTIN | naftifine hydrochloride | 0259-4126 | BENZYL ALCOHOL | |
| Merz Pharmaceuticals LLC | NAFTIN | naftifine hydrochloride | 0259-4126 | CETYL ALCOHOL | |
| Merz Pharmaceuticals LLC | NAFTIN | naftifine hydrochloride | 0259-4126 | CETYL ESTERS WAX | |
| Merz Pharmaceuticals LLC | NAFTIN | naftifine hydrochloride | 0259-4126 | ISOPROPYL MYRISTATE | |
| Merz Pharmaceuticals LLC | NAFTIN | naftifine hydrochloride | 0259-4126 | POLYSORBATE 60 | |
| Merz Pharmaceuticals LLC | NAFTIN | naftifine hydrochloride | 0259-4126 | SORBITAN MONOSTEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing NAFTIFINE HYDROCHLORIDE
Detailed excipient profiles for NAFTIFINE HYDROCHLORIDE
Excipient focus: ALCOHOL
NAFTIFINE HYDROCHLORIDE drug variants containing ALCOHOL
NAFTIFINE HYDROCHLORIDE drug variants not containing ALCOHOL
Excipient focus: BENZYL ALCOHOL
NAFTIFINE HYDROCHLORIDE drug variants containing BENZYL ALCOHOL
NAFTIFINE HYDROCHLORIDE drug variants not containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals of New York LLC | naftifine hydrochloride | 0115-1510 |
| Sebela Pharmaceuticals Inc | naftifine hydrochloride | 54766-770 |
| Physicians Total Care Inc | naftifine hydrochloride | 54868-2185 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOMER 934
NAFTIFINE HYDROCHLORIDE drug variants containing CARBOMER 934
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | naftifine hydrochloride | 54868-2185 |
| >Company | >Ingredient | >NDC |
NAFTIFINE HYDROCHLORIDE drug variants not containing CARBOMER 934
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
NAFTIFINE HYDROCHLORIDE drug variants containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals of New York LLC | naftifine hydrochloride | 0115-1510 |
| Sebela Pharmaceuticals Inc | naftifine hydrochloride | 54766-770 |
| >Company | >Ingredient | >NDC |
NAFTIFINE HYDROCHLORIDE drug variants not containing CARBOMER HOMOPOLYMER TYPE B
Excipient focus: CETYL ALCOHOL
NAFTIFINE HYDROCHLORIDE drug variants containing CETYL ALCOHOL
NAFTIFINE HYDROCHLORIDE drug variants not containing CETYL ALCOHOL
Excipient focus: CETYL ESTERS WAX
NAFTIFINE HYDROCHLORIDE drug variants containing CETYL ESTERS WAX
NAFTIFINE HYDROCHLORIDE drug variants not containing CETYL ESTERS WAX
Excipient focus: DIISOPROPANOLAMINE
NAFTIFINE HYDROCHLORIDE drug variants containing DIISOPROPANOLAMINE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals of New York LLC | naftifine hydrochloride | 0115-1510 |
| Sebela Pharmaceuticals Inc | naftifine hydrochloride | 54766-770 |
| Physicians Total Care Inc | naftifine hydrochloride | 54868-2185 |
| >Company | >Ingredient | >NDC |
NAFTIFINE HYDROCHLORIDE drug variants not containing DIISOPROPANOLAMINE
Excipient focus: EDETATE DISODIUM
NAFTIFINE HYDROCHLORIDE drug variants containing EDETATE DISODIUM
NAFTIFINE HYDROCHLORIDE drug variants not containing EDETATE DISODIUM
Excipient focus: HYDROCHLORIC ACID
NAFTIFINE HYDROCHLORIDE drug variants containing HYDROCHLORIC ACID
NAFTIFINE HYDROCHLORIDE drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYDROXYETHYL CELLULOSE
NAFTIFINE HYDROCHLORIDE drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | naftifine hydrochloride | 51672-1376 |
| Sebela Pharmaceuticals Inc | naftifine hydrochloride | 54766-772 |
| >Company | >Ingredient | >NDC |
NAFTIFINE HYDROCHLORIDE drug variants not containing HYDROXYETHYL CELLULOSE
Excipient focus: ISOPROPYL MYRISTATE
NAFTIFINE HYDROCHLORIDE drug variants containing ISOPROPYL MYRISTATE
NAFTIFINE HYDROCHLORIDE drug variants not containing ISOPROPYL MYRISTATE
Excipient focus: POLYSORBATE 20
NAFTIFINE HYDROCHLORIDE drug variants containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | naftifine hydrochloride | 51672-1376 |
| Sebela Pharmaceuticals Inc | naftifine hydrochloride | 54766-772 |
| >Company | >Ingredient | >NDC |
NAFTIFINE HYDROCHLORIDE drug variants not containing POLYSORBATE 20
Excipient focus: POLYSORBATE 60
NAFTIFINE HYDROCHLORIDE drug variants containing POLYSORBATE 60
NAFTIFINE HYDROCHLORIDE drug variants not containing POLYSORBATE 60
Excipient focus: POLYSORBATE 80
NAFTIFINE HYDROCHLORIDE drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals of New York LLC | naftifine hydrochloride | 0115-1510 |
| Sebela Pharmaceuticals Inc | naftifine hydrochloride | 54766-770 |
| Physicians Total Care Inc | naftifine hydrochloride | 54868-2185 |
| >Company | >Ingredient | >NDC |
NAFTIFINE HYDROCHLORIDE drug variants not containing POLYSORBATE 80
Excipient focus: PROPYLENE GLYCOL
NAFTIFINE HYDROCHLORIDE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | naftifine hydrochloride | 51672-1376 |
| Sebela Pharmaceuticals Inc | naftifine hydrochloride | 54766-772 |
| >Company | >Ingredient | >NDC |
NAFTIFINE HYDROCHLORIDE drug variants not containing PROPYLENE GLYCOL
Excipient focus: SODIUM HYDROXIDE
NAFTIFINE HYDROCHLORIDE drug variants containing SODIUM HYDROXIDE
NAFTIFINE HYDROCHLORIDE drug variants not containing SODIUM HYDROXIDE
Excipient focus: SORBITAN MONOSTEARATE
NAFTIFINE HYDROCHLORIDE drug variants containing SORBITAN MONOSTEARATE
NAFTIFINE HYDROCHLORIDE drug variants not containing SORBITAN MONOSTEARATE
Excipient focus: STEARYL ALCOHOL
NAFTIFINE HYDROCHLORIDE drug variants containing STEARYL ALCOHOL
NAFTIFINE HYDROCHLORIDE drug variants not containing STEARYL ALCOHOL
Excipient focus: TROLAMINE
NAFTIFINE HYDROCHLORIDE drug variants containing TROLAMINE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | naftifine hydrochloride | 51672-1376 |
| Sebela Pharmaceuticals Inc | naftifine hydrochloride | 54766-772 |
| >Company | >Ingredient | >NDC |
NAFTIFINE HYDROCHLORIDE drug variants not containing TROLAMINE
Excipient focus: WATER
NAFTIFINE HYDROCHLORIDE drug variants containing WATER
NAFTIFINE HYDROCHLORIDE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | naftifine hydrochloride | 54868-2185 |
| Physicians Total Care Inc | naftifine hydrochloride | 54868-2240 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
